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Abstract Elucidation of the three-dimensional structure of
phosphatidylinositol transfer protein K (PI-TPK) void of phos-
pholipid revealed a site of membrane association connected to a
channel for phospholipid binding. Near the top of the channel
speci¢c binding sites for the phosphorylcholine and phosphory-
linositol head groups were identi¢ed. The structure of this open
form suggests a mechanism by which PI-TPK preferentially
binds PI from a membrane interface. Modeling predicts that
upon association of PI-TPK with the membrane the inositol
moiety of bound PI is accessible from the medium. Upon release
from the membrane PI-TPK adopts a closed structure with the
phospholipid bound fully encapsulated. This structure provides
new insights as to how PI-TPK may play a role in PI metabo-
lism.
# 2002 Federation of European Biochemical Societies. Pub-
lished by Elsevier Science B.V. All rights reserved.
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1. Introduction
Phosphatidylinositol transfer protein (PI-TP) occurs in two
soluble isoforms (PI-TPK and PI-TPL) which are found in all
mammalian cells investigated to date [1]. Both proteins trans-
fer in vitro phosphatidylinositol (PI) and, to a lesser extent,
phosphatidylcholine (PC) between membranes. In addition,
PI-TPL is also able to transfer sphingomyelin (SM) [2].
Upon isolation from bovine brain two forms of PI-TPK
were identi¢ed which showed di¡erent isoelectric points.
This di¡erence was related to the presence of either PI or
PC in the lipid-binding site of the protein [3]. PI-TPK is highly
conserved among mammalian species with a sequence identity
of more than 99% [4,5]. The PI-TPL isoform is very homolo-
gous to PI-TPK with an identity of 77% [6]. Localization
studies using indirect immuno£uorescence and microinjection
of £uorescently labeled PI-TPs have shown that PI-TPK is
mainly localized in the cytosol and the nucleus whereas PI-
TPL is predominantly associated with the Golgi complex [2,7].
In search of a function PI-TPK and PI-TPL were extensively
assayed in reconstitution studies. Both PI-TPs were able to
stimulate the formation of constitutive secretory vesicles and
immature granules in a cell-free system containing trans-Golgi
membranes [8]. Furthermore, both proteins were able to re-
store GTPQS-stimulated protein secretion and phospholipase
C (PLC)-mediated inositol lipid signaling in cytosol-depleted
cells [9,10]. In contrast to this apparent similarity in function,
these isoforms gave rise to remarkable di¡erences in lipid
metabolism when overexpressed in NIH3T3 cells. In cells
with a two- to three-fold elevated level of PI-TPK a PI-speci¢c
phospholipase A2 (PLA2) was activated [11]. This activation
was not observed in cells overexpressing PI-TPL. Rather, in
these cells it was shown that under conditions where plasma
membrane SM was hydrolyzed to ceramide by exogenous
sphingomyelinase, PI-TPL was involved in maintaining the
steady-state levels of SM [12]. Possibly in line with their e¡ects
on lipid metabolism, the PI-TPK overexpressors display an
increased growth rate, whereas the growth rate of PI-TPL
overexpressors is decreased [11,12].
Another clue to the function of PI-TPK and PI-TPL comes
from studies in mice. As shown by Hamilton et al., the so-
called mouse vibrator mutation results in an 80% decrease of
PI-TPK levels in the brain, giving rise to severe neurodegen-
eration and juvenile death [13]. Interestingly, PI-TPK 3/3
mice develop to term but die soon after birth [14]. E¡orts to
generate a knock-out cell line lacking the alleles for PI-TPL
failed. This indicates that PI-TPL is an essential protein in
murine cells [14].
Another member of the PI-TP family is the retinal degen-
eration protein B (rdgB). This 170 kDa integral membrane
protein contains a PI-TP-like domain at the amino terminus.
It was ¢rst identi¢ed in Drosophila, where it is localized in the
photoreceptors, antennae and speci¢c regions of the brain.
RdgB is thought to be essential for photoreceptor function
[15]. The mammalian homolog of rdgB has also been identi-
¢ed [16]. The latest addition to the PI-TP family is the mam-
malian 38 kDa M-rdgBL which contains the PI-TP-like do-
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main, but lacks the transmembrane domain [17]. In the fol-
lowing we discuss the 3D-structures of the open and closed
form of mammalian PI-TPK and the implication of these
forms for the mode of action of PI-TPK at the membrane
interface.
2. The 3D-structures of PI-TPK
Recently, the crystal structures of rat PI-TPK carrying a PC
molecule and of mouse PI-TPK lacking a phospholipid mole-
cule were elucidated [18,19]. The sequences of mouse and rat
PI-TPK are nearly identical with a single conservative replace-
ment of Val167 for Ile167. The crystal structures of both PI-
TPKs show some remarkable di¡erences although the second-
ary structural elements are preserved (Fig. 1). The main struc-
tural feature is a concave L-sheet consisting of eight strands
(1^8). Both structures further consist of seven K-helices (A^G)
of which helices C^E are part of a relatively large loop be-
tween strands 6 and 8. This loop is referred to as the regu-
latory loop, which is postulated to be involved in the inter-
action of PI-TPK with lipid- and protein-modifying enzymes.
In addition to the regulatory loop, three other functional re-
gions can be identi¢ed. The main part of the structure is the
lipid-binding core, which consists of the L-sheet and two heli-
ces (A and F) facing the interior of the L-sheet. A loop con-
taining helix B acts as a lid to the lipid-binding core and is
designated as the lipid exchange loop. Finally, the fourth re-
gion is the C-terminal domain (residues 233^271) that con-
tains helix G. In PI-TPK containing PC the tail of this domain
(residues 261^271) is part of the lid (Fig. 1, left panel). When
the lid covers the lipid-binding cavity the structure is in a
closed conformation. In apo-PI-TPK the lipid exchange loop
has moved outward, resulting in an open conformation (Fig.
1, right panel). Together with this loop the C-terminal domain
is dislodged, accompanied by a partial unfolding of helix G
and a disordering of the C-terminal tail (residues 258^271).
The yeast PI-TP Sec14 shows no sequence homology with the
mammalian PI-TPK, yet it also contains a loop which acts as
a lid to the phospholipid-binding core [20]. The outward
movement of the lid is accompanied by a widening of the
lipid-binding cavity and creates a large opening (350 AO 2) at
the site of the lipid exchange loop. By £attening of the L-sheet
(strands 2^4) a small opening (75 AO 2) is formed at the oppo-
site side of the protein, resulting in the formation of a chan-
nel. The large opening exposes a hydrophobic surface, where-
as the small opening is of hydrophilic nature and close to the
site for lipid head-group binding.
3. The phospholipid-binding sites
Previous biochemical studies on the binding of PC and PI
to PI-TPK provided evidence for the presence of separate
binding sites for the phosphorylinositol and phosphorylcho-
line head group [3]. From competition binding experiments it
was estimated that the protein has a 16-fold higher a⁄nity for
PI than for PC [21]. The structure of the closed form shows
that the recognition site for the phosphorylcholine head group
is fully encapsulated and buried inside the protein. This site
consists of amino acid residues interacting with the phosphate
moiety (Gln22, Thr97, Thr114 and Lys195) and residues in-
teracting with the choline moiety (Glu86, Asn90 and Cys95)
(Fig. 2). As mentioned in [18], modeling of the inositol moiety
in this site is unsatisfactory and does not explain the polar
head-group preference of PI-TPK. Comparison of the closed
and open structures indicates that the phosphorylcholine-
binding site remains intact. However, as a consequence of
the formation of the lipid-binding channel, modeling studies
predict the induction of a separate binding site for the phos-
phorylinositol head group about 4 AO away from the phos-
phorylcholine-binding site towards the small channel opening
[19]. In the open form, the putative inositol-binding site con-
sists of Glu86 and Asn90 and the displaced residues Thr59
and Lys61, whereas the interaction with Cys95 is lost (Fig. 2).
Due to the shift of the lipid-binding site the amino acid res-
idues interacting with the phosphate moiety are limited to
Gln22 and Thr97. Lys61 and Lys195 are the only positively
charged residues directed towards the lipid cavity, but neither
make contact with the phosphate moiety of phosphorylinosi-
tol. It appears that Thr59 plays a crucial role in the binding of
the inositol head group as a mutation of this residue resulted
Fig. 1. A ribbon diagram of the closed (left panel) and open conformation (right panel) of PI-TPK from rat and mouse, respectively. The struc-
tures contain four functional regions, i.e. the lipid-binding core (blue) with the £exible part of the L-strand (dark blue), the regulatory loop
(green), the C-terminal region (red) and the lipid exchange loop (orange). The lipid molecule bound to the closed form is PC.
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in the abolishment of PI-transfer, whereas the transfer of PC
was not a¡ected [22]. The distinct preference of PI-TPK for PI
over PC can be explained by the formation of hydrogen bonds
between Glu86, Asn90, Thr59 and Lys61 of the inositol-bind-
ing site and the inositol hydroxyls. This hydrogen bond for-
mation does not occur with the choline moiety. In agreement
with this, electrospray time-of-£ight mass spectrometry anal-
ysis of the PI-TPK-lipid complex has shown that PI is much
stronger bound than PC [23].
By measuring the binding and transfer of molecular species
of PI and PC it was inferred that PI-TPK has separate binding
sites for the sn-1 and sn-2 acyl chains, with each site having a
distinct preference for a particular fatty acyl chain length.
Similarly, it was concluded that the acyl chains of PI are
probably accommodated in the same binding sites as the
acyl chains of PC [24]. In addition, time-resolved £uorescence
spectroscopy revealed that the sn-2 fatty acyl chains of both
phospholipids are completely immobilized in the lipid-binding
site [3]. The structural elucidation of PC in the lipid cavity of
the PC^PI-TPK complex has con¢rmed that the sn-1 and sn-2
acyl chains are accommodated in di¡erent sites [18].
4. Membrane association
The open structure of PI-TPK is taken to represent the
membrane-associated form, where the lipid-exchange loop
acts as a membrane anchor [19]. In support of this interaction
with the membrane, the injection of PI-TPK under a phospho-
lipid monolayer spread at the air-water interface, gives rise to
a slight increase in surface pressure [25]. In addition, associa-
tion of PI-TPK with membrane vesicles renders the protein
susceptible to proteolytic cleavage by trypsin at the C-terminal
residues Arg253 and Arg259 as a result of dislodging and
partially unfolding of the C-terminal region [26]. It is to be
noted that C-terminally truncated PI-TPKs demonstrated an
enhanced membrane a⁄nity and a more relaxed structure
when compared to full-length PI-TPK[27]. This suggests that
in the absence of the C-terminal tail the open membrane-
bound conformation is favored. Under these conditions trun-
cated PI-TPKs in which 18^20 amino acids were deleted from
the C-terminus, were inactive [27,28]. Upon interaction with
the membrane PI-TPK undergoes a structural rearrangement
so as to allow contact and interaction of the aromatic residues
Tyr103, Trp203 and Trp204, and positively charged residues
Lys105, Lys202 and Lys209 of the structurally invariant part
of the lipid-binding core with the phospholipid interface. In
addition, Lys68, Phe72 and Arg74 of the lipid exchange loop,
and Lys153 and possibly Lys156 of the regulatory loop may
also contribute to the membrane binding (Fig. 3A). Apart
from the Trp203^Trp204 pair in the putative membrane asso-
ciation site, it was reported that two adjacent tryptophan
residues are also part of a core bilayer insertion unit (TA-
PAS-1 microdomain) of the cAMP-speci¢c phosphodiesterase
Fig. 2. The PC head group-binding site in the closed form of PI-
TPK is extended to separate binding sites for the PC and PI head
group in the open form. The PI head group-binding site is predicted
from modeling [36]. As indicated by the amino acid residues in-
volved in the binding, the major part of the PC head group-binding
site is intact in the open form and 4 AO apart from the PI head
group-binding site. In binding phospholipids only one of the two
sites is occupied.
Fig. 3. A: Position of the amino acid residues involved in the asso-
ciation of PI-TPK with the membrane interface. B: Schematic repre-
sentation of the conformational changes when PI-TPK (blue shape)
binds to the membrane and when it is released into the medium.
Water-soluble PC^PI-TPK and PI^PI-TPK have the closed form and
PI-TPK at the interface the open form. The lipid exchange loop (or-
ange shape), which closes the lipid cavity of the water-soluble
forms, is inserted into the membrane when PI-TPK is associated
with the membrane interface. At the interface PC (green shape) is
inserted into the membrane in exchange for PI (yellow shape) that
is bound to the protein
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PDE4A1 [29]. In support of positively charged amino acid
residues being involved in membrane association, van Paridon
et al. have shown that binding of PI-TPK to phospholipid
vesicles increases when the membranes are more negatively
charged [30].
PI-TPK has a speci¢c protein kinase C-dependent phos-
phorylation site (i.e. Ser166) which is present in the regulatory
loop. To mimic phosphorylated serine, Ser166 was replaced
with an aspartic acid residue yielding a protein which lacked
phospholipid transfer activity [31]. This inactivation may re-
sult from Asp166 or phosphorylated Ser166 inducing struc-
tural rearrangements in the regulatory loop such that Lys153
and Lys156 present in this loop fail to interact with the mem-
brane interface. Phosphorylation of Ser166 is a prerequisite
for PI-TPK to be relocalized from the nucleus and cytosol to
the Golgi complex [31]. This speci¢c relocalization implies
that upon phosphorylation PI-TPK most likely associates
with a speci¢c docking protein on the Golgi.
As shown by Yoder et al. [18], PI-TPK carrying a PC mol-
ecule has a closed conformation which can be characterized as
the phospholipid transport intermediate (Fig. 3B). Upon bind-
ing to the membrane, the structure relaxes into the open con-
formation, which, as proposed by Schouten et al. [19], most
probably corresponds to the membrane-associated state. This
relaxation exposes the lipid-binding channel to the membrane
interface and presents separate binding sites for the phosphor-
ylcholine and phosphorylinositol head groups located close to
the hydrophilic opening at the far end of the channel. Given
the additional stability by hydrogen bonding, PI-TPK will
preferentially bind a PI molecule in exchange for a PC mol-
ecule. Extraction of either phospholipid from the membrane
interface may be facilitated by a low dielectric constant in the
channel, which would reduce the bilayer stability at the site of
interaction. Subsequent closing of the channel by the lipid
exchange loop and refolding of the C-terminus will dissociate
the phospholipid^PI-TPK complex from the membrane. It re-
mains to be established whether PI-TPK carrying PI has a
closed conformation similar to that of PI-TPK carrying PC.
If so, one would predict subtle structural rearrangements
around the binding site for the phosphorylinositol head
group, which is more bulky than the phosphorylcholine
head group. These subtle changes may o¡er an explanation
for the observation that PKC phosphorylates Ser166 in PI/PI-
TPK at a lower rate than in PC/PI-TPK [31]. It could be that
Ser166 in PC/PI-TPK is better accessible for the PKC or that
PKC has a higher a⁄nity.
5. Implications of the structure for PI-TPK functioning
Although the exact function of PI-TPK is still a matter of
debate, it is generally accepted that this protein is involved in
the presentation of PI to various inositol lipid-metabolizing
enzymes, yielding metabolites that are essential for lipid sig-
naling. Cunningham et al. have shown that PI-TPK is neces-
sary to reconstitute GTPQS-mediated PLCL signaling in per-
meabilized HL60 cells [32]. Subsequent reconstitution studies
using other cell lines showed that it was also able to stimulate
PLCQ and N [33,34]. In these studies it was proposed that PI-
TPK promotes the synthesis of phosphatidylinositol 4,5-bis-
phosphate (PIP2), which upon hydrolysis by PLC gives rise
to increased levels of inositol phosphates [32]. In this PLC-
signaling reaction PI-TPK may provide PI to PI 4-kinase and
PI 4,5-kinase for PIP2 to be synthesized at the plasma mem-
brane. It has also been proposed that PI bound to PI-TP is
directly presented to the kinases for sequential phosphoryla-
tion [32,33]. In this model PIP2 remains bound to PI-TP for it
to be presented directly to PLC. In a similar way, PI-TP may
also play a role in delivering PI to PI 3-kinases [35]. In the
case of PI being bound to PI-TPK at the membrane interface,
the inositol moiety is in front of the hydrophilic opening of
the lipid-binding channel. From modeling [36] it followed that
the hydroxyl groups at positions 3, 4 and 5 are most likely
accessible from the medium. Given the 75 AO 2 size of the small
opening it is unlikely that the PI-kinases can directly phos-
phorylate the bound PI. Another possibility remains that the
interaction of PI-kinases with PI-TPK at the interface gives
rise to a structural change so that PI can switch from the
lipid-binding site to the active site of the kinase. Phosphory-
lation of PI also occurs in the nucleus. Since PI is synthesized
in the endoplasmic reticulum, it could be possible that PI-TPK
is also required for supplying PI to the nuclear kinases [37].
Given that PC is synthesized in the nucleus [38], PI-TPK-
mediated delivery of PI into the nucleus could then be coupled
to a transfer of PC in the opposite direction. This proposed
role is in line with the cytosolic and nuclear localization of PI-
TPK and presumes a continuous £ux of PI-TPK between these
two compartments [7].
Overexpression of PI-TPK in NIH3T3 ¢broblast cells had a
profound e¡ect on PI metabolism. Equilibrium labeling of
these cells with myo-[3H]inositol demonstrated that, compared
with non-transfected cells, the overexpressors had increased
levels of glycerophosphoinositol, inositol 1-phosphate, inositol
2-phosphate and lysoPI. These results indicated that in
NIH3T3 cells PI-TPK activated a PI-speci¢c PLA2 rather
than a PLC [11]. Similar to the PI-kinases, it is feasible that
PLA2 interacts with PI-TPK, resulting in a transfer of PI to
the active site of PLA2. On the other hand, it is well possible
that PI-TPK takes PI to those membranes where the PI-spe-
ci¢c PLA2 is present.
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